89bio, Inc. Uncategorized Contracts & Agreements
6 Contracts & Agreements
- Description of Securities (Filed With SEC on March 1, 2024)
- Description of Securities (Filed With SEC on March 24, 2022)
- Description of Securities (Filed With SEC on March 25, 2021)
- Description of Securities (Filed With SEC on March 18, 2020)
- Sublicense Agreement by and between 89Bio Ltd. and ratiopharm GmbH, dated as of April 16, 2018 (Filed With SEC on October 11, 2019)
- Director Offer Letter, dated July 1, 2018, by and between 89Bio Ltd. and Michael Hayden (Filed With SEC on October 11, 2019)
